Astarte Medical And Tiny Health Join Forces To Optimize Gut Health For Vulnerable Preterm Infants

Astarte Medical, a leading pediatric clinical intelligence company, is forming a joint venture with Tiny Health, makers of gut microbiome tests for babies and expecting parents. The partners have agreed to develop a clinical-facing technology solution to support gut health for preterm and critically ill infants receiving care in the neonatal ICU.

By combining Astarte Medical’s proprietary NICUbiome(TM) dataset and NICUtrition EMR-integration platform with Tiny Health’s deep shotgun metagenomics sequencing and functional profiling expertise and capabilities, providers will be able to identify and stratify risks, as well as monitor the gut health of preterm babies.

“Nutrition for preterm infants is guided by two main factors: a baby’s age and weight. Today, technology allows us to measure and compare thousands of gut profiles, which can directly inform how we treat babies during the extremely formative first 1,000 days,” said Astarte Medical Chief Executive Officer Tracy Warren. “This partnership forms the basis of evidence-based precision nutrition care models for clinicians leveraging NICUtrition(R), with the goal to deliver more effective feeding to preterm babies to improve their growth, neurodevelopment and long-term immune health.”

Read the full article here